[Analysis of Short-Term Results after Introduction of Robotic Gastrectomy for Gastric Cancer at Our Hospital].

Q4 Medicine

Japanese Journal of Cancer and Chemotherapy Pub Date : 2024-04-01

Junji Kawada, Minami Maruyama, Tomonori Nomura, Manatsu Mizuno, Akio Fukada, Shinya Kidogami, Yoshiki Taniguchi, Kei Asukai, Hideki Osawa, Yukako Mokutani, Tomoya Kishimoto, Hajime Hirose, Ho Min Kim, Shinichi Yoshioka, Yo Sasaki

{"title":"[Analysis of Short-Term Results after Introduction of Robotic Gastrectomy for Gastric Cancer at Our Hospital].","authors":"Junji Kawada, Minami Maruyama, Tomonori Nomura, Manatsu Mizuno, Akio Fukada, Shinya Kidogami, Yoshiki Taniguchi, Kei Asukai, Hideki Osawa, Yukako Mokutani, Tomoya Kishimoto, Hajime Hirose, Ho Min Kim, Shinichi Yoshioka, Yo Sasaki","doi":"","DOIUrl":null,"url":null,"abstract":"Background: Robotic gastrectomy(RG)for gastric cancer(GC)has been covered by health insurance since 2018. In this study, we examined the results of RG for GC at our hospital during the initial period of its introduction.Materials and method: From August 2022 to May 2023, we retrospectively examined the surgical outcomes and short-term postoperative outcomes of the first 9 patients who underwent RG for GC at our hospital.Results: The median patient age was 77(67-82) years, gender was 4 males and 5 females, and distal gastrectomy was performed in all patients. The median operative time was 410(323-486)min, blood loss was 5(1-140)mL, postoperative hospital stay was less than 9 days in all patients, and there was no conversion to laparoscopic or open surgery. There were no postoperative complications of Clavien-Dindo Grade Ⅱ or above.Conclusion: In this study, RG for GC was performed safely without intraoperative or postoperative complications.","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Robotic gastrectomy(RG)for gastric cancer(GC)has been covered by health insurance since 2018. In this study, we examined the results of RG for GC at our hospital during the initial period of its introduction.

Materials and method: From August 2022 to May 2023, we retrospectively examined the surgical outcomes and short-term postoperative outcomes of the first 9 patients who underwent RG for GC at our hospital.

Results: The median patient age was 77(67-82) years, gender was 4 males and 5 females, and distal gastrectomy was performed in all patients. The median operative time was 410(323-486)min, blood loss was 5(1-140)mL, postoperative hospital stay was less than 9 days in all patients, and there was no conversion to laparoscopic or open surgery. There were no postoperative complications of Clavien-Dindo Grade Ⅱ or above.

Conclusion: In this study, RG for GC was performed safely without intraoperative or postoperative complications.

本刊更多论文

[本院引进机器人胃切除术治疗胃癌的短期效果分析]。

背景：机器人胃切除术（RG）治疗胃癌（GC）自2018年起纳入医保范围。在本研究中，我们考察了我院在引入机器人胃切除术初期的胃癌治疗效果：2022年8月至2023年5月，我们回顾性研究了我院首批9例接受RG治疗GC患者的手术效果和术后短期疗效：患者年龄中位数为 77（67-82）岁，性别为 4 男 5 女，所有患者均接受了远端胃切除术。中位手术时间为410（323-486）分钟，失血量为5（1-140）毫升，所有患者术后住院时间均少于9天，没有患者转为腹腔镜手术或开腹手术。术后无 Clavien-Dindo Ⅱ级或以上并发症：结论：本研究中，GC 的 RG 手术安全进行，无术中或术后并发症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Japanese Journal of Cancer and Chemotherapy Medicine-Medicine (all)

CiteScore

0.20

自引率

0.00%

发文量

337